메뉴 건너뛰기




Volumn 66, Issue 12, 2011, Pages 2892-2893

Comment on: Efficacy and safety of tigecycline: A systematic review and meta-analysis

Author keywords

Antibiotics; Dosing; Mortality

Indexed keywords

ANTIBIOTIC AGENT; CILASTATIN PLUS IMIPENEM; TIGECYCLINE;

EID: 81855190641     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr353     Document Type: Letter
Times cited : (9)

References (7)
  • 1
    • 80051692552 scopus 로고    scopus 로고
    • Efficacy and safety of tigecycline: a systematic review and meta-analysis
    • Yahav D, Lador A, Paul M et al. Efficacy and safety of tigecycline: a systematic review and meta-analysis. J Antimicrob Chemother 2011; 66: 1963-71.
    • (2011) J Antimicrob Chemother , vol.66 , pp. 1963-1971
    • Yahav, D.1    Lador, A.2    Paul, M.3
  • 2
    • 78649935284 scopus 로고    scopus 로고
    • Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock
    • Varghese JM, Roberts JA, Lipman J. Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock. Crit Care Clin 2011; 27: 19-34.
    • (2011) Crit Care Clin , vol.27 , pp. 19-34
    • Varghese, J.M.1    Roberts, J.A.2    Lipman, J.3
  • 3
    • 77649218608 scopus 로고    scopus 로고
    • Appropriate use of antimicrobials: the peculiarity of septic patients
    • Scaglione F. Appropriate use of antimicrobials: the peculiarity of septic patients. Int J Antimicrob Agents 2009; 34 Suppl 4: S52-4.
    • (2009) Int J Antimicrob Agents , vol.34 , Issue.SUPPL. 4
    • Scaglione, F.1
  • 4
    • 23844486729 scopus 로고    scopus 로고
    • The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data
    • Babinchak T, Ellis-Grosse E, Dartois N et al. The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data. Clin Infect Dis 2005; 41 Suppl 5: S354-67.
    • (2005) Clin Infect Dis , vol.41 , Issue.SUPPL. 5
    • Babinchak, T.1    Ellis-Grosse, E.2    Dartois, N.3
  • 5
    • 77954684523 scopus 로고    scopus 로고
    • Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial
    • Chen Z, Wu J, Zhang Y et al. Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial. BMC Infect Dis 2010; 10: 217.
    • (2010) BMC Infect Dis , vol.10 , pp. 217
    • Chen, Z.1    Wu, J.2    Zhang, Y.3
  • 6
    • 45549109768 scopus 로고    scopus 로고
    • Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia
    • Tanaseanu C, Bergallo C, Teglia O et al. Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia. Diagn Microbiol Infect Dis 2008; 61: 329-38.
    • (2008) Diagn Microbiol Infect Dis , vol.61 , pp. 329-338
    • Tanaseanu, C.1    Bergallo, C.2    Teglia, O.3
  • 7
    • 77956576770 scopus 로고    scopus 로고
    • Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
    • for the 311 Study Group
    • Freire AT, Melnyk V, Kim MJ et al. for the 311 Study Group. Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia. Diagn Microbiol Infect Dis 2010; 68: 140-51.
    • (2010) Diagn Microbiol Infect Dis , vol.68 , pp. 140-151
    • Freire, A.T.1    Melnyk, V.2    Kim, M.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.